Progression of QRS duration: a potential surrogate marker of survival in ATTRwt amyloidosis patients
In wild-type transthyretin amyloidosis (ATTRwt), the deposition of transthyretin in the myocardium leads to progressive heart failure. However, little is known about the short-term natural progression of this disease and potential predictors of outcome.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 October 2025
|
| In: |
Orphanet journal of rare diseases
Year: 2025, Jahrgang: 20, Heft: 1, Pages: 1-9 |
| ISSN: | 1750-1172 |
| DOI: | 10.1186/s13023-025-04078-4 |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s13023-025-04078-4 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1186/s13023-025-04078-4 
|
| Verfasserangaben: | Selina Hein, Fabian aus dem Siepen, Sonja M. Zierleyn, Maximilian Knoll, Hugo A. Katus, Norbert Frey, Arnt V. Kristen |
| Zusammenfassung: | In wild-type transthyretin amyloidosis (ATTRwt), the deposition of transthyretin in the myocardium leads to progressive heart failure. However, little is known about the short-term natural progression of this disease and potential predictors of outcome. |
|---|---|
| Beschreibung: | Gesehen am 14.01.2026 |
| Beschreibung: | Online Resource |
| ISSN: | 1750-1172 |
| DOI: | 10.1186/s13023-025-04078-4 |